Home » Authors » Mark Lawson

Mark Lawson

Articles

ARTICLES

Amrad Reports Positive AM336 Trial Results, Raises A$15.5M

March 6, 2002

Amrad Reports Positive AM336 Trial Results, Raises A$15.5M

March 6, 2002

Australian Researchers Isolate Gene Implicated In Hay Fever

Feb. 20, 2002

Australian Researchers Isolate Gene Implicated In Hay Fever

Feb. 20, 2002

Metabolic Eyeing Phase IIb Trial In Obesity After Positive IIa Study

Feb. 13, 2002

Metabolic Eyeing Phase IIb Trial In Obesity After Positive IIa Study

Feb. 13, 2002

Biota Purchases U.S. Company With Antivirals Program For $8M

May 30, 2001

Biota Purchases U.S. Company With Antivirals Program For $8M

May 30, 2001

Rothschild Planning New Fund For Australian Biotech Firms

May 16, 2001

Rothschild Planning New Fund For Australian Biotech Firms

May 16, 2001

View All Articles by Mark Lawson

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...